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Abstract
The aim of this study was to determine the prevalence of metabolic syndrome among hypertensive patients. A crosssectional study conducted at Al-Rayan Specialized Hospital, Mukalla, Hadramout during (2/2015 - 4/2016). From
345 patients, 207 were diagnosed as metabolic syndrome (60%), with mean age (57.9±9.2) years was significantly
higher than that of patients without the syndrome (44.7±6.6) years (p ˂0.0001). Females with the syndrome were
significantly higher than males (67.6% and 32.4% respectively) compared with patients without, (p ˂0.0001). As
Hypertension was present in all studied patients, diabetes was the commonest metabolic syndrome component in
patients with the syndrome (79.2%), followed by the high waist circumference (76.3%), then high triglycerides
(66.2%) and the least was low HDL (59.9%). There was 58% of patients with metabolic syndrome had four metabolic
syndrome components, 32.8% with five and only 7.2% had only three components. The prevalence of metabolic
syndrome among hypertensive patients was high. It was more common in females and older age. Diabetes and the
central obesity were the most frequent syndrome components. More than half of patients had four components, but a
considerable number of patients were with the all the five components.
Keywords: Metabolic Syndrome, Hypertension, Diabetes, Hadramout, Yemen.

Introduction:
Hypertension (HTN) and Metabolic syndrome
(MetS) are highly prevalent diseases that present
a global challenge [9,16]. In 2000, approximately
1 billion people worldwide (26.4% of the adult
population) were estimated to have HTN and this
is likely to increase to over 1.5 billion by 2025 as
a result of aging population in many developed
countries, and an increasing incidence of HTN in
developing countries [16]. It is estimated that
around 20-25% of the world’s adult population
has MetS and they are twice as likely to die from
it; and they are three times more likely to have a
heart attack or stroke compared with people
without the syndrome [33]. When HTN and
MetS components co-exist in an individual they
potentiate one another leading to synergism that
increase the total risk [24]. Hypertension is one
of the major manifestations of the group of
clinical abnormalities that characterize MetS
[19]. Use of some antihypertensive agents like
diuretics or β-adrenergic blocking agents may
worsen insulin resistance and increase the risk of
developing cardiovascular disease [15].
Even though there are different studies done on
the prevalence of MetS in different parts of the
world [14,15,25,35], in neighbour countries
[2,3,6,26]; and few reports on MetS in the area
were specifically performed among hypertensive
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individuals [29]. In Republic of Yemen, only
three published studies were performed on MetS
[1,4,7], in the fourth study was our work in
Hadramout [5]. Hence, the aim of this study was
to determine the prevalence of MetS among
hypertensive patients in Hadramout.
Subjects and Methods:
This prospective cross-sectional hospital-based
study was carried out at the medical department
and outpatient clinic of Al-Rayan specialized
Hospital, Mukalla, Hadramout, Republic of
Yemen, during the period from February 2015 to
April 2016. Previously hypertensive patients
were submitted to the study after exclusion
criteria had been applied, which were: Type 1
diabetes mellitus (DM), secondary DM or HTN,
any evidence of non-diabetic or nonhypertensive renal disease, or severe renal
disease, severe heart failure (New York Heart
Association class III or more), liver disease, and
pregnancy.
Ethically, a written consent from most patients or
his/her guardian was taken as an agreement to
participate in the study, few patients were illiterate
or old and verbal agreement was declared.
All patients underwent detailed History taking
and
clinical
examination,
including
measurements of weight, waist circumference
(WC), and blood pressure. Fasting venous blood
was sampled from an antecubital vein from all
patients for the measurement of plasma glucose
(FPG),
high-density
lipoprotein
(HDL),
triglycerides (TGs), urea and creatinine.
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Metabolic syndrome was diagnosed, according to
The National Cholesterol Education Program
(NCEP), Adult Treatment Panel III (ATP-III), in
patients fulfilling three or more of the following [11]:
1- Abdominal obesity (waist circumference >
102 cm in men and > 88 cm in women).
2- TGs >1.7 mmol/l (150 mg /dl),
3- HDL <1.04 mmol/L [40 mg/dL] for men and
<1.30 mmol/L [50 mg/dL] for women)
4- High fasting plasma glucose (FPG) ≥6.1
mmol/L [≥110 mg/dL] or taking antihyperglycemic drugs).
5- High blood pressure (systolic blood pressure
≥130 mmHg or diastolic blood pressure ≥85
mmHg or taking antihypertensive drugs.
The sample size was estimated using the formula
for descriptive study (n= Zα2 X p X q/ d2) [10],
where n is the sample desirable, Zα is the
confidence level at 95% (1.96), d is the desirable
precision at 5% (0.05), p is the previous
prevalence of MetS in hypertensive patients in
Kuwait; (34%) [29], q is 1-p which is equal to
0.66. Based on the above formula, the minimal
sample size was 345. Then, systematic sampling
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was applied and every second a participant was
selected using systematic random sampling
technique.
Data were processed by The Statistical Package
for Social Sciences (SPSS) software version 20.0
(IBM Corporation, Armonk, NY, USA). The
paired "t" test was applied to compare means and
Pearson's chi-square test to compare gender and
MetS components. Also we estimated odds ratio
(OR) and the resulting confidence interval (95%
CI) for all categorical variables. All statistical
hypothesis tests were 2-sided, and p values <0.05
were considered statistically significant. Microsoft
office Excel 2010 was used to form the figures.
Results
On the basis of ATPIII criteria [11], 60% (207 /
345) patients fulfilled the criteria for MetS and
138 (40%) without MetS (Figure1). The mean
age of Mets patients was (57.9±9.2) years, and
was highly significant comparing with patients
without the syndrome (44.7±6.6) years. All
means of the five components of MetS were
significantly higher in MetS patients than those
of non-MetS ones (Table 1).

Figure 1: Patients with and without Metabolic Syndrome (N=345)
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Table 1 Parameters of patients with and without Metabolic Syndrome
Metabolic syndrome (N=345)
Parameter

P value

Yes (n=207)

No (n= 138 )

Mean ± SD

Mean ± SD

Age (years)

57.9 ± 9.2

44.7±6.6

˂ 0.0001

WC1 (cm)2

99.2±6.3

85.6±5

˂ 0.0001

145±11.1

142.1±14.1

0.037

DBP (mm.Hg)

89.8±5.9

88.3±6.8

0.035

TGs5 (mg/dl)

3

SBP (mm.Hg)
4

154.1±13.3

124.8±11.9

˂ 0.0001

6

41.8±8.7

49±4.8

˂ 0.0001

7

132.2±15.1

97.2±5.1.

˂ 0.0001

HDL (mg/dl)
FPG (mg/dl)
1

Waist Circumference 2centimeters
Lipoprotein 7Fasting Plasma Glucose

3

Systolic Blood Pressure

Females (140, 67.5%) were significantly higher
than males with MetS (67, 32.4%), [OR 0.28,
95% CI (0.18-0.44), p ˂ 0.0001]. After HTN,
DM was the most common MetS component in
MetS patients (164, 79.2%), followed by high
WC (158, 76.3%), high TGs (137, 66.2%), and
low HDL (124, 59.9%) was the least frequent
MetS component. All these components were
higher in frequency among MetS patients

4

Diastolic Blood Pressure

5

Triglycerides 6High-Density

comparing non-MetS patients with statistical
significance, and they had stronger association
with MetS than non-MetS patients with logistic
regression; diabetes [OR 2.24(1.38-3.62)95% CI
(1.38-3.62), p = 0.0009], high WC [OR 2.01,
95% CI (1.23-3.27), p ˂ 0.0001], raised TGs [OR
4.04, 95% CI (2.56-6.39), p ˂ 0.0001], and low
HDL [OR 6.75, 95% CI (4.04-11.3), p ˂ 0.0001]
(Table 2).

Table 2 Frequency of Gender and Components of Metabolic Syndrome
Metabolic syndrome (N=207)

OR1 (95% CI)2

P value

0.28 (0.18-0.44)

˂ 0.0001

Yes (n=207)

No (n= 138 )

Male

67 (32.4%)

51(37%)

Female

140 (67.6%)

87(63%)

High WC3

158 (76.3%)

39 (44.3%)

2.01(1.23-3.27)

˂ 0.0001

Diabetes

164(79.2%)

87(63%)

2.24(1.38-3.62)

0.0009

Raised TGs4

137(66.2%)

45(32.6%)

4.04(2.56-6.39)

˂ 0.0001

Low HDL5

124(59.9%)

25(18.1%)

6.75(4.04-11.3)

˂ 0.0001

Sex

Odds Ratio. 295% Confidence Interval. 3Waist circumference. 4Triglycerides. 5High-density lipoprotein.

1

Regarding the distribution of MetS patients, 120 (58%) had 4 Components (criteria) of MteS, 72 (34.8%)
had 5 components, and only 15 (7.2%) were with 3 components. (Figure2).
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15 patients
(07.2%)

3 Criteria

120
patients
(58%)

4 Criteria
72 patients
(34.8%)

5 Criteria
0

50

100

150

No of Patients
Figure 2 Distribution of Patients according to Number of Metabolic syndrome Components
Discussion:
This study showed a high prevalence of MetS
among hypertensive patients attending follow-up
at the medical clinic and department of Al-Rayan
Specialized Hospital, using the NCEP-ATP
criteria (60%). Although many studies worldwide were in the range of 30-50% [17,18,21,23],
higher figures were reported [12,30]. This
variation was also recorded in the same region,
in the Middle East, Yasin et al. [34] in Jordan
reported about twice than Sorkhou et al. [29] in
Kuwait (65% and 34% respectively). In India,
Govindula et al. [12], Thakur et al. [32], and
Salegre et al. [27], found that the prevalence of
MetS were (82.5%, 68.6% and 49%
respectively). The possible explanations for the
variation could be genetic disparities between
populations,
ethnicity,
socio-demographic
characteristics, lifestyle, duration of HTN and
experiences of antihypertensive treatment.
Recently Tedewos et al, found that the
prevalence of MetS in urban inhabitants was
82.8% [31], therefore, it calls for a critical
attention to create awareness for individuals
living in urban situation concerning how to
modify their life style in order to limit/prevent
MetS risks.
This study revealed that MteS patients were
older than the non-MetS, with female
predominance, and this was supported by many
studies [20,28], the syndrome affecting less than
10% of people in their 20s and 40% of people in
their 60s [13] and recently Nolan et al, in a
pooled analysis reported only 5-7% among
young adult [22].
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The frequency of each MetS component among
hypertensive patient was variable, the most
frequent MetS component among MetS patients
in this work after HTN was DM, followed by
high WC, high TGs and the least frequent was
low HDL, Selagre et al, in India, [27] was very
similar to our findings except that WC and TGs
replaced their arrangements, but in many studies
around the globe, WC was the most frequent, and
DM was the least [8,32,34,35].
More than 90% of our MetS patients had ˃3
components (58% with 4 and 34.8% with all the
5 components) while only 7.2% were with three
components, while many studied showed that
more patients were with three component, and
the least were with 5 components (10.2-17%)
[8,12,27,31], so, our people have a higher risk
for coronary artery diseases and stroke, and
primary and secondary prevention must be more
effective.
Conclusion:
The prevalence of metabolic syndrome among
hypertensive patients was 60%. It was more
common in females and older age. Diabetes is
the most common component followed by high
waist circumference (central obesity), high serum
triglycerides and least frequent one was the
serum low HDL Most patients had ˃3
components of the syndrome.
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مجمة جامعة حضرموت لمعموم الطبيعية والتطبيقية المجمد ,15العدد  ,1يونيو 2018م

املتالزمة االستقالبية بني مرضى ارتفاع ضغط الدم
يف حضرموت -اجلمهورية اليمنية

حسين سعيد الغزالي

رشيد محمد بامخاله
الممخص

كان اليدف من ىذه الدراسة ىو معرفة انتشار المتالزمة االستقالبية عند مرضى ارتفاع ضغط الدم .وىي دراسة مقطعية أجريت في
مستشفى الريان التخصصي بالمكال حضرموت خالل الفترة 2016/4-2015/2م .من  345مريضاً 207 ,منيم تم تشخيصيم كمرضى

بالمتالزمة االستقالبية ( )%60ومتوسط أعمارىم ( )9.2 ± 57.9عام و ىو أعمى بداللة إحصائية عن متوسط أعمار المرضى بدون
المتالزمة ( )6.6 ± 44.7عام ( )p ˂0.0001نسبة اإلناث المرضى بالمتالزمة كانت أعمى وبداللة من نسبة الذكور (  %67.6و
 %32.4عمى الترتيب) مقارنة بالمرضى بدون المتالزمة ) .(p ˂0.0001كون ارتفاع ضغط الدم لدى جميع المرضى ,فإن داء السكري

ىو األكثر نسبة بين مرضى المتالزمة ( )%79.2يميو ارتفاع محيط الخصر ( ,)%76.3ثم ارتفاع الدىون الثالثية ( )%66.2وأقميم ىو
نسبة انخفاض البروتين الدىني عالي الكثافة ( .)%59.9و كان  %58من مرضى المتالزمة لدييم أربعة من مكونات المتالزمة ,و
 %32.8لدييم خمسة ,بينما  % 7.2منيم فقط لدييم ثالثة مكونات من مكونات المتالزمة .نسبة انتشار المتالزمة االستقالبية عند مرضى
ارتفاع ضغط الدم كان مرتفعا .و ىو أكثر بين اإلناث و كبار السن .داء السكري والسمنة كانا األكثر شيوعا بين مكونات المتالزمة .أكثر
من نصف المرضى كان لدييم  4مكونات بينما ىناك نسبة كبيرة منيم لدييم كافة مكونات المتالزمة الخمسة.
الكممات المفتاحية :المتالزمة االستقالبية ,ارتفاع ضغط الدم ,السكري ,حضرموت ,اليمن.
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